Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy.
Epidemiologic studies have suggested an association between hepatitis C virus (HCV) infection and antigendriven lymphoproliferative disorders, in particular marginal zone lymphomas. Antiviral therapy has been shown to exert an anti-lymphoma effect in these indolent B-cell lymphoproliferations, with survival gains observed. However, these protocols have traditionally incorporated interferon. We describe a patient with chronic hepatitis C, immune thrombocytopenia, and splenic marginal zone lymphoma who, after eradication of HCV with sofosbuvir and ribavirin, exhibited complete remission of both hematologic conditions. With the numerous new potent drugs currently available, the future looks positive with highly efficacious interferon-free regimens for HCV therapy.
Toronto Centre for Liver Disease, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Lucy Y
LY
Lim
Toronto Centre for Liver Disease, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Danie
D
La
Laboratory Medicine Program (Transfusion Medicine) and Department of Medical Oncology/Hematology, University Health Network, Toronto, Ontario, Canada.
Christine M
CM
Cserti-Gazdewich
Toronto Centre for Liver Disease, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Hemant
H
Shah